Infectious Disease

Latest News

C Difficile Treatment Shows Positive Results in Phase 2 Study
C Difficile Treatment Shows Positive Results in Phase 2 Study

September 5th 2024

CRS3123 is a novel, small molecule, antibiotic drug candidate that selectively inhibits 1 form of the bacterial methionyl-tRNA synthetase enzyme and is not affected by resistance to any existing classes of antibiotics.

FDA Approves Expanded Use of ACAM2000 Vaccine for Mpox Amid Public Health Emergency
FDA Approves Expanded Use of ACAM2000 Vaccine for Mpox Amid Public Health Emergency

August 30th 2024

Disparities Hinder HPV Vaccine Goals in USAPI Jurisdictions
Disparities Hinder HPV Vaccine Goals in USAPI Jurisdictions

August 22nd 2024

FDA Grants Marketing Authorization to First-Ever OTC Syphilis Test
FDA Grants Marketing Authorization to First-Ever OTC Syphilis Test

August 16th 2024

Dengue Vaccine TAK-003 Confirmed to be Safe, Effective
Dengue Vaccine TAK-003 Confirmed to be Safe, Effective

August 13th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.